Saama Stock

saama.comHealthcare / Other HealthcareFounded: 1997Funding to Date: $75.75MM

Saama is the developer of an AI clinical analytics platform designed to enable the life sciences industry to conduct faster and safer clinical development and regulatory programs.

Register To Buy and Sell Shares

For more details on financing and valuation for Saama, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Saama’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Saama.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Simon Ho
Chief Financial Officer
Sagar Anisingaraju
Chief Strategy Officer
Kenneth Massey
Chief Life Sciences Officer
Suresh Katta
Chief Executive Officer & Board Member
Rajeev Dadia
Chief Technology Officer & Chief Client Care Officer

Board Members

Daniel Fairfax
Self
M.R. Rangaswami
Saama
James Karis
Self
Marc McMorris
Carrick Capital Partners
Ajit Shetty Ph.D
Self
Kenneth Coleman
Carrick Capital Partners

Frequently Asked Questions About Saama’s Stock

plusminus
Can you buy Saama’s stock?
Saama is not publicly traded on NYSE or NASDAQ in the U.S. To buy Saama’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Saama’s stock?
Yes, you can sell stock of a private company like Saama. Forge can help you sell your Saama stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Saama’s stock price?
Saama is a privately held company and therefore does not have a public stock price. However, you may access Saama’s private market stock price with Forge Data.
plusminus
What is Saama’s stock ticker symbol?
Saama does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors
Press Release Saama Technologies, Inc. ("Saama") today announced the appointment of six individuals to its Board of Directors.Saama board members now include:Suresh Katta, Founder and CEO of SaamaIan Read, former CEO and Executive Chairman of PfizerClive Meanwell,...
Saama Teams With Oracle to Offer Life Sciences Industry AI-Enabled Applications to Accelerate Clinical Trials
Press Release Saama Technologies, Inc. ("Saama") announced today that they have collaborated with Oracle to integrate Saama's smart applications with the Oracle Health Sciences Clinical One platform. This collaboration empowers pharmaceutical companies with artificial...
Saama Launches Active Safety Analytics for Pharma (ASAP), Co-built With Gilead to Transform Safety Surveillance
Press Release Saama Technologies, Inc. ("Saama"), the #1 AI clinical analytics platform company, announced today the launch of the new Active Safety Analytics for Pharma (ASAP) product. ASAP is the first validated pharmacovigilance solution to leverage the U.S. Food...
Updated on: Apr 18, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.